The CDC has issued interim effectiveness estimates for the 2024-2025 seasonal influenza and 2024-2025 COVID-19 vaccines.
The FDA’s Vaccines and Related Biological Products Advisory Committee had been scheduled to meet Thursday to weigh in on the composition of the flu shots, but that session was canceled without ...
“The FDA anticipates that there will be an adequate and diverse supply of approved trivalent seasonal influenza vaccines” for the upcoming virus season, it said in a statement.There are ...
After the FDA canceled a key advisory meeting, government doctors stepped in to propose a trivalent flu vaccine for the upcoming 2025-26 season.
Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.